2014Pharmaceutical biotechnologyRequires access

Research and Development of Monoclonal Antibody Drugs

LI Zhuang-li

Open publisher page 0 citations

Abstract

Hybridoma technique has made mouse monoclonal antibody. With the recombinant DNA technology and antibody library technology,people have modified mouse monoclonal antibody to overcome its clinical application defects,developed human-mouse chimeric antibody and humanized antibody and full human antibody. Because of good specificity and significant effects,monoclonal antibody drugs become a research hotspot of biopharmaceutical companies. With the development of biotechnology,a variety of monoclonal antibody derivatives are generated,including antibody-drug conjugates,small molecular antibodies and bispecific antibodies. In this article,the history,progress and prospect of therapeutic antibodies are reviewed.

About this research paper

What this paper is about

Hybridoma technique has made mouse monoclonal antibody. With the recombinant DNA technology and antibody library technology,people have modified mouse monoclonal antibody to overcome its clinical application defects,developed human-mouse chimeric antibody and humanized antibody and full human antibody. Because of good specificity and significant effects,monoclonal antibody drugs become a research hotspot of biopharmaceutical companies. With the development of biotechnology,a variety of monoclonal antibody derivatives are generated,including antibody-drug conjugates,small molecular antibodies and bispecific antibodies. In this article,the history,progress and prospect of therapeutic antibodies are reviewed.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Hybridoma technique has made mouse monoclonal antibody. With the recombinant DNA technology and antibody library technology,people have modified mouse monoclonal antibody to overcome its clinical application defects,developed human-mouse chimeric antibody and humanized antibody and full human antibody. Because of good specificity and significant effects,monoclonal antibody drugs become a research hotspot of biopharmaceutical companies. With the development of biotechnology,a variety of monoclonal antibody derivatives are generated,including antibody-drug conjugates,small molecular antibodies and bispecific antibodies. In this article,the history,progress and prospect of therapeutic antibodies are reviewed.

Key concepts: Monoclonal antibody, Antibody, Biopharmaceutical, Recombinant DNA, Humanized antibody, Antibody-drug conjugate, Virology, Molecular biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Research and Development of Monoclonal Antibody Drugs — Research Paper | ScholarLens